Uticaj komorbiditeta na dužinu trajanja hospitalizacije nakon aortokoronarog bajpasa

Andrea Vučković; Katarina Đurić; Marko Filipović; Danijela Tasić; Nebojša  Tasić

doi:10.5937/mp76-47296

Andrea Vučković Institut za kardiovaskularne bolesti Dedinje
Katarina Đurić Institut za kardiovaskularne bolesti Dedinje
Marko Filipović
Danijela Tasić
Nebojša Tasić

DOI: https://doi.org/10.5937/mp76-47296

Ključne reči: aortokoronarni bajpas, dužina hospitalizacije, komorbiditeti

Sažetak

SAŽETAK

Uvod: Ishemijska bolest srca predstavlja jedan od vodećih uzroka smrti u svetu, a nastaje kao posledica neravnoteže između potreba miokarda za kiseonikom i njegovim dotokom putem krvi. Najčešći uzrok ishemijske bolesti jeste ateroskleroza koronarnih arterija. Glavne metode lečenja obuhvataju revaskularizaciju miokarda putem ugradnje aortokoronarnog bajpasa ili perkutanom koronarnom intervencijom, kao i farmakološku terapiju.

Cilj rada: Cilj ovog rada jeste analiza uticaja komorbiditeta, životnih navika i herediteta na dužinu trajanja hospitalizacije nakon aortokoronarnog bajpasa.

Materijal i metode: Podaci za ovaj rad dobijeni su iz medicinske dokumenatacije pacijenata operisanih na Institutu za kardiovaskularne bolesti Dedinje u periodu od 30.11.2022. do 19.01.2023. godine. Reč je o deskriptivnoj epidemiološkoj studiji. Statistička obrada je izvršena u SPSS 21.0 programu.

Rezultati: U periodu od 30.11.2022. godine do 19.01.2023. godine operisano je ukupno 106 pacijenata, od kojih je 76 (71,7%) bilo muškaraca. Medijana starosti pacijenata je iznosila 66 (opseg 39-78) godina. Pacijenti koji su imali istovremenu operaciju valvula i bajpas operaciju bili su statistički značajno duže hospitalizovani u odnosu na pacijente koji nisu imali operaciju valvula (p=0,008). Rezultati istraživanja ukazuju da su starost (p=0,001) i NYHA stepen srčane insuficijencije (p=0,006) u statistički značajnoj pozitivnoj korelaciji sa trajanjem hospitalizacije. Prisustvo ostalih ispitivanih komorbiditeta, hereditarnog opterećenja i pušenja, u ovom istraživanju, nije statistički značajno povezano sa dužinom hospitalizacije nakon aortokoronarnog bajpasa (p>0.05).

Zaključak: Praktična primena rezultata ove studije ogleda se u mogućnosti predikcije dužine hospitalizacije na osnovu prisustva određenih komorbiditeta, odnosno uznapredovale srčane insuficijencije, operacije valvula i starosti pacijenata..

Reference

1. Pepine CJ, Nichols WW. The pathophysiology of chronic ischemic heart disease. Clin Cardiol. 2007 Feb; 30(2 Suppl 1): :I4-9.

2. Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021 Apr 8; 22(8): 3850.

3. Henderson A. Coronary heart disease: overview. Lancet. 1996 Nov; 348 Suppl 1: s1-4.

4. Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017 Jun; 18(6): 331-344.

5. Bruning RS, Sturek M. Benefits of exercise training on coronary blood flow in coronary artery disease patients. Prog Cardiovasc Dis. 2015 Mar-Apr; 57(5): 443-53.

6. Kubal C, Srinivasan AK, Grayson AD, Fabri BM, Chalmers JA. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg. 2005 May; 79(5): 1570-6.

7. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005 Jun 28; 111(25): 3481-8.

8. Yerokun BA, Williams JB, Gaca J, Smith PK, Roe MT. Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes. Coron Artery Dis. 2016 Jun; 27(4): 319-26.

9. Breeman A, Hordijk-Trion M, Lenzen M, Hoeks S, Ottervanger JP, Bertrand M et al; Euro Heart Survey on Coronary Revascularization. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization. J Thorac Cardiovasc Surg. 2006 Nov; 132(5): 1001-9.

10. Steg PG, Ducrocq G. Future of the Prevention and Treatment of Coronary Artery Disease. Circ J. 2016 Apr 25; 80(5): 1067-72.

11. Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015 Mar-Apr; 28(2): 283-93.

12. Tinica G, Vartic CL, Mocanu V, Baran D, Butcovan D. Preoperative graft assessment in aortocoronary bypass surgery. Exp Ther Med. 2016 Aug; 12(2): 804-808.

13. Sajja LR, Mannam G, Pantula NR, Sompalli S. Role of radial artery graft in coronary artery bypass grafting. Ann Thorac Surg. 2005 Jun; 79(6): 2180-8.

14. Stenvall H, Tierala I, Räsänen P, Laine M, Sintonen H, Roine RP. Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease. Eur Heart J Qual Care Clin Outcomes. 2017 Jan 1; 3(1): 74-82.

15. Torabipour A, Arab M, Zeraati H, Rashidian A, Sari AA, Sarzaiem MR. Multivariate Analysis of Factors Influencing Length of Hospital Stay after Coronary Artery Bypass Surgery in Tehran, Iran. Acta Med Iran. 2016 Feb; 54(2): 124-33.

16. Bottle A, Mozid A, Grocott HP, Walters MR, Lees KR, Aylin P. et al. Preoperative risk factors in 10 418 patients with prior myocardial infarction and 5241 patients with prior unstable angina undergoing elective coronary artery bypass graft surgery. Br J Anaesth. 2013 Sep; 111(3): 417-23.

17. Almashrafi A, Alsabti H, Mukaddirov M, Balan B, Aylin P. Factors associated with prolonged length of stay following cardiac surgery in a major referral hospital in Oman: a retrospective observational study. BMJ Open. 2016 Jun 8; 6(6): e010764.

18. Peterson ED, Coombs LP, Ferguson TB, Shroyer AL, DeLong ER, Grover FL et al. Hospital variability in length of stay after coronary artery bypass surgery: results from the Society of Thoracic Surgeon's National Cardiac Database. Ann Thorac Surg. 2002 Aug; 74(2): 464-73.

19. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002 Aug 7; 40(3): 418-23.

20. Engel AM, McDonough S, Smith JM. Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg. 2009 Dec; 88(6): 1793-800.

21. Butterworth J, James R, Prielipp R, Cerese J, Livingston J, Burnett D. Female gender associates with increased duration of intubation and length of stay after coronary artery surgery. CABG Clinical Benchmarking Database Participants. Anesthesiology. 2000 Feb; 92(2): 414-24.

22. Mehta GS, LaPar DJ, Bhamidipati CM, Kern JA, Kron IL, Upchurch GR J. et al. Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting. Surgery. 2012 Jul; 152(1): 5-11.

23. Lazar HL, Fitzgerald C, Gross S, Heeren T, Aldea GS, Shemin RJ. Determinants of length of stay after coronary artery bypass graft surgery. Circulation. 1995 Nov 1; 92(9 Suppl): II20-4.